The 9th TPD & Induced Proximity Summit 2026, will bring together the TPD and induced-proximity community across discovery, degrader optimisation, preclinical development, translational strategy, clinical development and emerging technologies.
TCG Lifesciences will be part of these conversations, bringing expertise in PROTAC and molecular-glue chemistry, linker and E3-ligand chemistry, analogue generation and PROTAC library synthesis, alongside in vitro pharmacology and DMPK capabilities including ADME and PK. TCGLS’s TPD platform leverages 25+ years of integrated drug discovery expertise and has supported the synthesis of 3,000+ membered PROTAC libraries, contributing to leads currently advancing through clinical trials.
Attendee: Dr. Sanjoy Kumar Mahanty, Vice President, Head of Business Development-NA
Book A Meeting